Black Box Warnings Should Be Simplified For Better Compliance, Study Finds
Executive Summary
"Black box" warnings in drug labeling should be made clearer and simpler to improve physician adherence to the warnings and to prevent adverse drug events, according to a study published in the Archives of Internal Medicine
You may also be interested in...
Boxed Warnings, Drug Watch Are Policy Goals Of Drug Safety Oversight Board
FDA's Drug Safety Oversight Board should start shifting its focus toward broader policy questions - like standards for boxed warnings - in addition to addressing emerging safety issues for specific products, DSOB Executive Director Susan Cummins suggested
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011